Market Research Report
Adhesion Barrier Market Size, Share & Trends Analysis Report By Product (Synthetic, Natural), By Application (Cardiovascular, Neurological), By Formulation (Film/Mesh, Gel), And Segment Forecasts, 2018 - 2026
|Published by||Grand View Research, Inc.||Product code||726434|
|Published||Content info||119 Pages
Delivery time: 2-3 business days
|Adhesion Barrier Market Size, Share & Trends Analysis Report By Product (Synthetic, Natural), By Application (Cardiovascular, Neurological), By Formulation (Film/Mesh, Gel), And Segment Forecasts, 2018 - 2026|
|Published: August 8, 2018||Content info: 119 Pages||
The global adhesion barrier market size is expected to reach USD 1.13 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 7.1% over the forecast period. Rising geriatric population and prevalence of chronic diseases are the key factors driving the market growth. Increasing awareness regarding the benefits of using adhesion barrier in post-operative procedures is also contributing toward the market growth.
Moreover, rising cases of sports-related injuries and number of surgeries would also have a positive impact on the market demand. For instance, according to the Safe Kids Worldwide survey of emergency room records in 2012, every 25 seconds a young athlete visited a hospital emergency room due to a sports-related injury. Such huge number of cases of sports injuries is anticipated to bolster the market growth in the coming years.
The synthetic adhesion barrier segment is anticipated to expand at a lucrative CAGR of over 7.0% during the forecast period owing to the cost effectiveness of these barriers as compared to the natural adhesion barriers
Hyaluronic acid synthetic adhesion barrier accounted for the largest share in 2017 with a market revenue of USD 147.25 million
Film/mesh formulated adhesion barrier held the largest share in 2017 due to wide use of this formulation
North America led the market in 2017, with a share of more than 47.0%, owing to developed healthcare infrastructure and increased number of surgeries along with customer awareness about the usage of adhesion barrier
Asian countries are estimated to witness the highest growth in market, due to increasing population in the region and changing lifestyle leading to the rising incidences of Cardiovascular Diseases (CVDs) in the region
Some of the key companies in the global market are Johnson & Johnson; Sanofi S.A.; Baxter International, Inc.; Becton, Dickinson and Company; Integra LifeSciences Holdings Corporation; Anika Therapeutics, Inc.; Atrium Medical Corporation (A Part of Getinge Group); FzioMed, Inc.; MAST Biosurgery, Inc.; and Innocoll Holdings PLC.